Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00355
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 16, 2018
Authors
Publisher
Frontiers Media SA